Pfizer Inc deal with GlaxoSmithKline plc will have no India impact

Ruling out any impact on GSK's India business, company sources said in India the pharma entity owned and manufactured products such as Iodex and Ostocalcium, which were marketed by GSK Consumer

The much-hyped global agreement between GlaxoSmithKline plc (GSK) and Pfizer Inc to combine their consumer businesses does not seem to affect their Indian entities as the major brands sold here are not part of the global deal. 

Both GSK Consumer Healthcare and Pfizer are listed entities here. In India GSK operates through two entities — GSK Pharmaceuticals and GSK Consumer Healthcare. Only recently, GSK Consumer has divested its malted drink brand Horlicks (along with other nutrition beverages such as Boost, Maltova etc) to Hindustan Unilever Ltd. (HUL) to which the former has also given the distribution rights for its other